Impact of prostate cancer multifocality on its biology and treatment.
暂无分享,去创建一个
[1] B. G. Blijenberg,et al. Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.
[2] D. Bostwick,et al. Three-dimensional prostate mapping biopsy has a potentially significant impact on prostate cancer management. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] J. Srigley,et al. Multifocal high grade prostatic intraepithelial neoplasia is a significant risk factor for prostatic adenocarcinoma. , 2009, The Journal of urology.
[4] V. Mouraviev,et al. Pathologic basis of focal therapy for early-stage prostate cancer , 2009, Nature Reviews Urology.
[5] A. Zlotta,et al. Focal Therapy Will Be the Future Treatment Modality: The Motion ''Con'' , 2009 .
[6] V. Mouraviev,et al. Focal Targeted Therapy Will Be a Future Treatment Modality for Early Stage Prostate Cancer , 2009 .
[7] C. Magi-Galluzzi,et al. CAN SATURATION BIOPSY PREDICT SIGNIFICANT CANCER NODULE LOCALIZATION IN RADICAL PROSTATECTOMY SPECIMENS: A CORRELATIVE STUDY AND IMPLICATIONS FOR FOCAL THERAPY FOR PROSTATE CANCER , 2009 .
[8] V. Mouraviev,et al. Nerve-sparing focal cryoablation of prostate cancer , 2009, Current opinion in urology.
[9] K. Stamatiou,et al. The phenomenon of multifocality does not affect the biologic behavior of histologic prostate carcinoma. , 2009, Medical science monitor : international medical journal of experimental and clinical research.
[10] Mark A Rubin,et al. Evaluating localized prostate cancer and identifying candidates for focal therapy. , 2008, Urology.
[11] L. Egevad. Recent trends in gleason grading of prostate cancer. II. Prognosis, reproducibility and reporting. , 2008, Analytical and quantitative cytology and histology.
[12] J. Moul,et al. Pathologic stage T2a and T2b prostate cancer in the recent prostate‐specific antigen era: Implications for unilateral ablative therapy , 2008, The Prostate.
[13] Athanase Billis,et al. The impact of the 2005 international society of urological pathology consensus conference on standard Gleason grading of prostatic carcinoma in needle biopsies. , 2008, The Journal of urology.
[14] L. Egevad. Recent trends in Gleason grading of prostate cancer: I. Pattern interpretation. , 2008, Analytical and quantitative cytology and histology.
[15] A. Partin,et al. Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. , 2008, The Journal of urology.
[16] L. Egevad,et al. Correlation of modified Gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens. , 2008, Analytical and quantitative cytology and histology.
[17] D. Bostwick,et al. Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer. , 2008, Urology.
[18] L. Egevad,et al. Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. , 2008, Analytical and quantitative cytology and histology.
[19] Oliver Sartor,et al. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. , 2007, The Journal of urology.
[20] M. Rubin,et al. TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. , 2007, Urology.
[21] P. Pierorazio,et al. Outcome after cytoreductive nephrectomy for metastatic renal cell carcinoma is predicted by fractional percentage of tumour volume removed , 2007, BJU international.
[22] P. Pierorazio,et al. High‐grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy , 2007, BJU international.
[23] J. Jones,et al. Focal or Subtotal Therapy for Early Stage Prostate Cancer , 2007, Current treatment options in oncology.
[24] J. Moul,et al. Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer , 2007, Cancer.
[25] Liang Cheng,et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. , 2005, Urology.
[26] John Boyages,et al. Multifocal and multicentric breast cancer: does each focus matter? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] L. Egevad,et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2005, The American journal of surgical pathology.
[28] Liang Cheng,et al. Anatomic distribution and pathologic characterization of small-volume prostate cancer (<0.5 ml) in whole-mount prostatectomy specimens , 2005, Modern Pathology.
[29] Ferran Algaba,et al. Gleason grading of prostate cancer in needle biopsies or radical prostatectomy specimens: contemporary approach, current clinical significance and sources of pathology discrepancies , 2005, BJU international.
[30] M. Dietlein,et al. Incidental multifocal papillary microcarcinomas of the thyroid: Is subtotal thyroidectomy combined with radioiodine ablation enough? , 2005, Nuclear medicine communications.
[31] Lang Li,et al. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate , 2004, Cancer.
[32] T. Stamey,et al. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. , 2003, The Journal of urology.
[33] J. Cheville,et al. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. , 2003, The Journal of urology.
[34] A. Barrier,et al. Early gastric carcinoma: spread and multicentricity , 2002, Gastric Cancer.
[35] T. Stamey,et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. , 2002, Urology.
[36] C. Windischberger,et al. Spatial Distribution of Prostate Cancers Undetected on Initial Needle Biopsies , 2001, European Urology.
[37] D. Johnston,et al. Detailed mapping of prostate carcinoma foci , 2000, Cancer.
[38] S. Egawa,et al. Infrequent involvement of the anterior base in low-risk patients with clinically localized prostate cancer and its possible significance in definitive radiation therapy. , 2000, Japanese journal of clinical oncology.
[39] J. Hanley,et al. Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. , 1999, JAMA.
[40] M. Banerjee,et al. Racial differences and prognostic significance of tumor location in radical prostatectomy specimens , 1998, The Prostate.
[41] D J Ruiter,et al. HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS , 1996, The Journal of pathology.
[42] A. Partin,et al. Original Articles: Prostate Cancer , 1995 .
[43] G. Miller,et al. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. , 1994, The Journal of urology.
[44] D. Bostwick,et al. Staging of early prostate cancer: a proposed tumor volume-based prognostic index. , 1993, Urology.
[45] T. Stamey,et al. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors , 1992, Cancer.
[46] D P Byar,et al. Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies , 1972 .
[47] R. Giudicelli,et al. Multifocal T4 non-small cell lung cancer: a subset with improved prognosis. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[48] J. Presti,et al. Prostate biopsy: current status and limitations. , 2007, Reviews in urology.
[49] P. Walsh,et al. Pathological features of hereditary prostate cancer. , 1995, The Journal of urology.